Passamonti 2017 MYSEC-PM for post-PV and post-ET myelofibrosis. Score = 0.15*age + hemoglobin <11 g/dL (2) + circulating blasts ≥3% (2) + CALR-unmutated (2) + platelets <150×10^9/L (1) + constitutional symptoms (1). Low <11, intermediate_1 ≥11 and <14, intermediate_2 ≥14 and <16, high ≥16. Not DIPSS (PMF), not GIPSS, not a transplant listing. magent does not sequence CALR.
| Network | Scheme | Amount | Pay To |
|---|---|---|---|
| Base | exact | $0.005000 USDC | 0x836B...9Ee2 |